MSB11022 in moderate to severe plaque psoriasis

Update Il y a 4 ans
Reference: EUCTR2015-003287-37

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of the trial is to demonstrate equivalence in efficacy of MSB11022 in subjects with moderate to severe chronic plaque psoriasis.


Inclusion criteria

  • Moderate to Severe Plaque Psoriasis

Links